Dennis C. Marshall

No ORCID on file · 1 paper in corpus

article 2001

Subcutaneously administered repronex® in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment

·doi:10.1016/s0015-0282(01)01856-8

ObjectiveTo determine the efficacy and safety of Repronex SC as compared with Repronex IM and Pergonal IM in patients undergoing ovulation induction.DesignRandomized, open-label, multicenter, parallel group study.SettingTen academic and pri…